We have a proven track record in supporting field trials with our comprehensive services, including Clinical Trial Kits (CTKs), downstream sample processing, and laboratory analysis. We provide tailored solutions to the specific needs of both adult and paediatric participants, ensuring all planned sampling timepoints are covered with precision. We have experience of working directly with clinical sites and via a central laboratory.
With our expertise and global reach, we excel in providing tailored logistics solutions, from initial planning through to sample analysis, supporting the success of your preclinical & clinical research programs (Phase I, II, III).
Our bespoke CTKs are designed to meet the specific requirements of your study. For example, each kit could include individually wrapped sterile swabs and labelled collection tubes containing transport matrices, such as Universal Transport Medium (UTM) or our proprietary RSV Stabilisation Transport Matrix (STM), ensuring sample integrity throughout the trial.
We ensure that CTKs are provided in batches and shipped globally to central laboratories for distribution to trial sites. After sample collection and freezing, samples are shipped back to hLAB on dry ice for aliquoting and analysis, including multi pathogen screening, RT-qPCR, and cell-based infectivity assays.
We can validate commercially available sample transport matrices to ensure they meet the specific needs for your clinical program. In addition, we can provide hLAB’s proprietary RSV stabilisation matrix, which is specifically designed to address the challenge of maintaining RSV sample integrity during storage and shipment. Validated for long-term stability at -80ºC and flexible storage conditions, this matrix ensures reliable viral load measurement, making it ideal for RSV field trials and human challenge studies.
1,400+ kits supplied
1,700+ plaque assays performed
1,800+ swabs processed
170+ BioFire Multi Respiratory Pathogen Screens
Our specialised virology laboratory enabled the biotech company to conduct rigorous and reliable assessments of RSV viral loads across multiple sites and trials. hLAB’s high throughput and precise diagnostic capabilities were instrumental in developing and validating the effectiveness of the RSV Stabilisation Transport Matrix and contributed significantly to the overall success of the clinical development programme.
This partnership highlights the importance of specialised laboratory support in complex, multi-centre clinical trials, particularly in the field of virology, where precise and reliable data are crucial for the development of effective therapeutic and diagnostic solutions.
